BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27098274)

  • 1. MicroRNA and gynecologic cancers.
    Kanekura K; Nishi H; Isaka K; Kuroda M
    J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.
    Logan M; Hawkins SM
    Clin Sci (Lond); 2015 Feb; 128(3):153-80. PubMed ID: 25294164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor markers in gynecological tumors.
    Rustin GJ
    Curr Opin Oncol; 1996 Sep; 8(5):426-31. PubMed ID: 8914810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of gynecologic cancer.
    Whang JD; Lee JH
    J Korean Med Sci; 1997 Oct; 12(5):383-9. PubMed ID: 9364294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnosis and prognosis in gynecologic oncology.
    Silverberg SG
    Arch Pathol Lab Med; 1999 Nov; 123(11):1035-40. PubMed ID: 10539903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Gynecologic Cancer Society (IGCS) 2016: Meeting report.
    Del Carmen MG; Rice LW
    Gynecol Oncol; 2017 Jan; 144(1):11-15. PubMed ID: 27847107
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of PET in gynecologic malignancy.
    Grigsby PW
    Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.
    Zafrakas M; Petschke B; Donner A; Fritzsche F; Kristiansen G; Knüchel R; Dahl E
    BMC Cancer; 2006 Apr; 6():88. PubMed ID: 16603086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular staging of gynecological cancer: What is the future?
    Binder PS; Prat J; Mutch DG
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):776-89. PubMed ID: 25934522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular genetics of gyn malignancies.
    Taylor RR; Teneriello MG; Nash JD; Park RC; Birrer MJ
    Oncology (Williston Park); 1994 Oct; 8(10):63-70, 73; discussion 73, 78-82. PubMed ID: 7803216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer.
    Hanžek A; Siatka C; Duc AE
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7981-7993. PubMed ID: 36914786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Office screening for gynecologic cancer.
    Zweizig SL
    Clin Obstet Gynecol; 1999 Jun; 42(2):267-75. PubMed ID: 10370846
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular diagnostic techniques in gynaecologic cancer].
    Salvesen HB; Iversen OE; Tropé C
    Tidsskr Nor Laegeforen; 2005 Nov; 125(22):3120-3. PubMed ID: 16299569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt Signaling in Gynecologic Malignancies.
    McMellen A; Woodruff ER; Corr BR; Bitler BG; Moroney MR
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gynecologic malignancies in older women.
    Mirhashemi R; Nieves-Neira W; Averette HE
    Oncology (Williston Park); 2001 May; 15(5):580-6; discussion 592-4, 597-8. PubMed ID: 11396354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
    Salani R; Backes FJ; Fung MF; Holschneider CH; Parker LP; Bristow RE; Goff BA
    Am J Obstet Gynecol; 2011 Jun; 204(6):466-78. PubMed ID: 21752752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging of gynecologic malignancies.
    Ascher SM; Takahama J; Jha RC
    Top Magn Reson Imaging; 2001 Apr; 12(2):105-29. PubMed ID: 11296804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA and the pathogenesis of ovarian cancer--a new horizon for molecular diagnostics and treatment?
    Kuhlmann JD; Rasch J; Wimberger P; Kasimir-Bauer S
    Clin Chem Lab Med; 2012 Jan; 50(4):601-15. PubMed ID: 22505556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gynecologic cancers.
    Blair AR; Casas CM
    Prim Care; 2009 Mar; 36(1):115-30, ix. PubMed ID: 19231605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.